Post Melvin M D & Associates S C is categorized under Physicians Offices in Chicago, IL and active since 1974.
Post Melvin M D & Associates S C was established in 1974, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Melvin Post at the company’s single location by writing to 858 West Armitage Avenue 317, Chicago, Illinois IL 60614 or by phoning (918) 465-3388. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Post Melvin M D & Associates S C |
| Contact Person: | Melvin Post |
| Address: | 858 West Armitage Avenue 317, Chicago, Illinois 60614 |
| Phone Number: | (918) 465-3388 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1974 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Post Melvin M D & Associates S C was started in 1974 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Melvin Post for inquiries that concern Post Melvin M D & Associates S C by calling the company number (918) 465-3388, as your correspondence is most welcome. Additionally, the physical location of the single location of Post Melvin M D & Associates S C can be found at the coordinates as well as the street address 858 West Armitage Avenue 317 in Chicago, Illinois 60614.
For its online presence, you may visit Post Melvin M D & Associates S C’s website at and engage with its social media outlets through on Twitter and on Facebook.